Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
9.68
+0.24 (2.54%)
At close: Oct 14, 2026, 4:00 PM EDT
9.68
0.00 (0.00%)
After-hours: Oct 14, 2026, 4:10 PM EDT
Haleon Market Cap
Haleon has a market cap or net worth of $43.01 billion as of October 14, 2026. Its market cap has increased by 5.91% in one year.
Market Cap
43.01B
Enterprise Value
52.93B
1-Year Change
5.91%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since July 18, 2022, Haleon's market cap has increased from $34.14B to $43.01B, an increase of 25.97%. That is a compound annual growth rate of 5.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 43.01B | -4.27% |
| Dec 31, 2025 | 44.93B | 5.03% |
| Dec 31, 2024 | 42.77B | 13.06% |
| Dec 29, 2023 | 37.83B | 3.87% |
| Dec 30, 2022 | 36.42B | 6.67% |
| Jul 18, 2022 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 60.67B |
| Teva Pharmaceutical Industries | 48.51B |
| Zoetis | 31.29B |
| United Therapeutics | 23.40B |
| Viatris | 20.35B |
| Neurocrine Biosciences | 13.79B |
| Elanco Animal Health | 11.30B |
| Dr. Reddy's Laboratories | 10.70B |